Shire plc and its subsidiaries (collectively referred to as either “Shire” or the “Company”) is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions.
Company profile
Ticker
SHPG
Exchange
Website
Employees
Location
Fiscal year end
Industry (SIC)
Former names
Shire Ltd., Shire Pharmaceuticals Group PLC
SEC CIK
Corporate docs
SHPG stock data
Latest filings (excl ownership)
15-15D
Suspension of duty to report
7 Feb 19
15-15D
Suspension of duty to report
7 Feb 19
15-12B
Securities registration termination
7 Feb 19
EFFECT
Notice of effectiveness
7 Feb 19
POS AM
Prospectus update (post-effective amendment)
4 Feb 19
S-8 POS
Registration of securities for employees (post-effective amendment)
4 Feb 19
S-8 POS
Registration of securities for employees (post-effective amendment)
4 Feb 19
S-8 POS
Registration of securities for employees (post-effective amendment)
4 Feb 19
S-8 POS
Registration of securities for employees (post-effective amendment)
4 Feb 19
POSASR
Automatic shelf registration (post-effective amendment)
4 Feb 19
Latest ownership filings
SC 13G
Shire plc
15 Feb 19
SC 13G/A
Beneficial ownership report (amended)
11 Jan 19
SC 13G/A
Beneficial ownership report (amended)
10 Jan 19
4
Translate Bio, Inc.
2 Jul 18
11-K
Annual report of employee stock purchases
29 Jun 18
11-K
Annual report of employee stock purchases
28 Jun 18
3
Translate Bio, Inc.
27 Jun 18
SC 13G/A
Beneficial ownership report (amended)
30 Jan 18
11-K
Annual report of employee stock purchases
28 Jun 17
11-K
Annual report of employee stock purchases
22 Jun 17
Institutional ownership, Q3 2019
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|